zanamivir (Dectova®) accepted for use within NHSScotland

Source:
Scottish Medicines Consortium - SMC
Publisher:
Scottish Medicines Consortium
Publication date:
09 December 2019

Abstract

The SMC has accepted zanamivir for the treatment of complicated and potentially life-threatening influenza A or B virus infection in adult and paediatric patients (aged = 6 months) under certain circumstances. Zanamivir should be used in accordance with official guidance.